Aton (EPA:ALTAO)

Market Cap	7.12M +13.2%
Revenue (ttm)	661.00K +7.7%
Net Income	-962.00K
EPS	-0.00
Shares Out	828.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,294,641
Open	0.0096
Previous Close	0.0096
Day's Range	0.0084 - 0.0098
52-Week Range	0.0050 - 0.0290
Beta	0.82
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Aton

Aton operates as a bioscience company in France. It engages in preclinical and clinical services, production of monoclonal antibodies, and laboratory equipment production, as well as provision of human tissues. The company is involved in development of biomaterials and reagents for diagnostics, as well as preclinical research services. Aton was founded in 1998 and is headquartered in Strasbourg, France.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 13
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTAO

Financial Performance

In 2025, Aton's revenue was 661,000, an increase of 7.65% compared to the previous year's 614,000. Losses were -962,000, -12.62% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error